ArticleJournal of applied clinical medical physics2025
Clinical evaluation of the aperture shape controller in volumetric modulated arc therapy: Effects on MLC and jaw motion complexity, plan quality, and deliverability.
Article in Journal of applied clinical medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The smoothing factor in breast intensity-modulated radiotherapy: dosimetric impact and a predictive model of plan acceptability.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2026Article
- Clinical evaluation of the aperture shape controller in volumetric modulated arc therapy: Effects on MLC and jaw motion complexity, plan quality, and deliverability.Journal of applied clinical medical physics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study comprehensively evaluated the impact of aperture shape controller (ASC) on volumetric modulated arc therapy (VMAT) clinical treatment planning.
methodsA total of 248 VMAT plans for head and neck, prostate, post mastectomy breast, gastric MALT lymphoma, rectum, and Lung SBRT for treatments performed between 2018 and 2023 were retrospectively enrolled. These treatment plans were divided into two groups: before (ASC-OFF group) and after (ASC-ON group) the clinical implementation of ASC. The performance of ASC in terms of plan complexity was evaluated by between group comparisons of the multi-leaf collimator (MLC) modulation complexity score (MCS
resultsThe overall MCS
conclusionsThe use of ASC reduced the complexity of MLC motions without compromising the plan quality. Furthermore, this study found that ASC allows jaw tracking to be more effective.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.